StonvexLoading…
StonvexStonvexStonvexCore line items from DXCM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.19B | $4.66B | $3.40B | $2.19B |
Operating Income | $255.30M | $911.80M | $588.80M | $346.30M |
Net Income | $199.50M | $836.30M | $569.00M | $285.20M |
EPS (Diluted) | $0.51 | $2.09 | $1.42 | $0.71 |
Total Assets | $6.63B | $6.34B | $7.50B | $7.33B |
Total Liabilities | $3.68B | $3.59B | $4.77B | $4.75B |
Cash & Equivalents | $1.12B | $917.70M | $1.84B | $1.16B |
Free Cash Flow OCF − CapEx | $449.00M | $1.08B | $885.10M | $305.70M |
Shares Outstanding | 385.90M | 384.80M | 390.00M | 392.20M |